---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-381879"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2026-09-03T20:06:14+00:00"
generated_at: "2026-09-03T20:07:22.748737+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Teva to terminate ADS program; ADSs exchange for NYSE-listed ordinary shares on Sept 14, 2026

## Summary
- Amendment No. 1 to deposit agreement executed Aug 31, 2026; each ADS exchanges for one ordinary share.
- ADS program termination effective at open of business Sept 14, 2026; all outstanding ADSs cancelled.
- Ordinary shares will be listed on NYSE; ADS holders become direct shareholders of Teva.
- Depositary Citibank, N.A. involved; ADR form updated accordingly.

## SEC filing metadata
- accession: 0001193125-26-381879
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2026-09-03T20:06:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312526381879/0001193125-26-381879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312526381879/d174614d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-381879
- JSON: https://secwatch.observer/filing/0001193125-26-381879.json
- Plain text: https://secwatch.observer/filing/0001193125-26-381879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.